O.K. Sorry. There's been quite a few filings to buy.
27-Aug-2015 2:05 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 25 Filed by: DALY KEVIN
27-Aug-2015 1:58 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 20 Filed by: THOMAS TOM
26-Aug-2015 8:30 AM ET Market Wire Iteris to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015
25-Aug-2015 5:45 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 24 Filed by: MINER GREG
24-Aug-2015 7:36 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 20 Filed by: DALY KEVIN
24-Aug-2015 6:52 PM ET EDGAR SEC Filings Form 4/A ITERIS, INC. For: Aug 18 Filed by: DALY KEVIN
20-Aug-2015 7:13 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 18 Filed by: DALY KEVIN
20-Aug-2015 4:12 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 18 Filed by: MINER GREG
Here's another theory. Around the last two weeks of July they get the Conservis deal and they set up a booth at the an Ag conference where they got 30 Ag businesses setting up meetings, 30 from one conference.
A week or so later insiders start buying.
From CC transcript:
Of significant note we had a fantastic show in the InfoAg at St. Louis in the fourth week of July with over 30 meetings with potential ClearAg partners and customers of global scale many of whom actively sought us out at the meeting.
Several trends are indicative of the changes we've made over the past quarter. The first is the introduction of the new component line which I mentioned earlier. This new class of products significantly enhances the ability to integrate ClearAg with third party software systems such as SMIS, as illustrated by our recent Conservis customer announcement. The second is incorporation of an element of customer specific engineering as a component of major ClearAg relationships. This maybe reflected as modeling-as-a-service or other purpose designed auxiliary capabilities that address unique interests of the customer. We recently announced our first ClearAg modeling-as-a-service contract with the Minnesota Wheat Growers Association.
Wow! I just added at $3.95 and I'm still up 72%. Nice run up on the good news about funding.
Interesting theory. Here's another. They like the pipeline and want to buy so they can sell later at a higher price.
Yes.I added. I was tempted to add today on the breakout from the flag formation.This was a big announcement so if it's trading up, it bodes well for higher prices.
The new investor must be sold on the prospects for the products. If you read the filing, the new investor is highly qualified to be on the BOD.
I also like ARIS, ITI, DYSL, among others.
Dump all dead weight, focus on core competencies to get to the black. I believe new CEO will turn this around so I'll be looking to accumulate more if he can show us how new products are producing revs and if he can get rid of any non performing assets.
Really nice deal with added benefit of a really qualified BOD coming on board to participate in the upside to AXGN products as they begin to reach a tipping point in acceptance in this BIG market.
But we'll see how the market reacts...
Last three Q's in a row sequential growth in top line.
This was achieved with a drag of up to $.8M in slowing Contract revs., which went into backlog and now the slowdown is expected to stop.
CLYC took a long time to develop and there was no ROE for this investment. But with the new contract win - starting now - it's in production and will contribute for years to come. Dual mode detectors hand held is pretty big market- ports airports etc.
Dichrotec was a drag in terms of costs. The costs are about over yet the pipeline of deals -based on the new opportunities- is just starting.
Then there's Xcede:
When a private funding deal is announced(if they go that route)shareholders will get to see what the percent of DYSLs ownership will be in Xcede and what the XcedeTech is worth at the time of funding. We should get to participate in future revs from Xcede but more importantly- in the increasing worth of the overall biotec unit. As it proceeds to a future round of funding the worth should go up. As it proceeds through trials and FDA approval the worth should sky rocket and DYSL shareholders will have an equity interest since DYSL itself should have an equity interest. That's my limited understanding of that.
Due to the low float there was volatility to the upside so I wouldn't expect to see the intraday high for a while.
The next announcement may be about hiring Xcede management. They will be getting options I suppose. I can't see how that would cause a spike in DYSL's stock. It may. But the funding announcement should spike us. We'll see. I believe it's coming. We were promised CLYC ROI and it's here. Dihrotec deals and they seem to be coming. A partnership deal and it's being worked on, I believe.
It can take a long time for a stock like this to blow; you just have to wait it out. If you see any new
institutions trying to get on board after the presentation then you know you really have a winner. I'll be looking for a new price target over the magic $5 that exceeds what some still consider the penny stock territory.
The low float makes for volatility to the upside so we are probably not going to the yesterday's intraday high any time too soon.
A close at over $4.08 would be a ten year high. That and a new price target would mean there's no real resistance. The chart would develop a golden cross and be quite bullish looking---in a "don't leave without me" sort of way that plays to the potential investors emotions. But we'll see if anything in the presentation makes a case for such a bullish scenario unfolding.
It's nice to bring a chart that's breaking out to the presentation.
Right now I'm busy selling into the explosion of the stock I recommended here yesterday. Just hold MITK everyone. I know what I'm talking about.
Not at all. The zeitgeist of the board was tarnished by you and other posters. The stock had high expectations, the company got into a lawsuit, had a lumpy, confusing start with it's revenues.You just murk up the board. You can be funny at times but you add nothing to the understanding or the facts. The board is better off without you.
My biggest holding in the micro cap genre. Hope it holds.
Long term this company ahs solid management and recurring revs. positive insider action, organic growth along with proven acquisitions. Let's see where it settles after some day traders may have some fun.
If we are in a bear market- hold stocks with recurring revs that are priced fairly and have improving metrics and fundamentals and are run by winners.
100% agree that MITK is a great long term hold now.
If you back off that last Q's non recurring expense and look at the steady growth in the top line it's a solid, profitable growth play.
Getting here was long and there were mishaps. The lawsuit and the lumpy revenue model and the option and insider action adding to confusion.
BUT these are resolved. Yet we have jack***** posting here. If these mishaps did not happen this would be a wonderful board. Too bad. Here's the good thing, though.
You can have a solid growth play that has too high an expectation and froth built in. It could take months or years to grow the profits until the stock price is justified. The good news is, imo, that is not the case here.
Here are the facts from the last income statement: Steady growth in top and bottom line. $1.25 M in profits, sans non recurring expenses. No real end to this nicely improving picture in near term sight.
In a bear market rallies are SOLD. You can short stocks with bad fundamentals and hope you are right that it IS a bear. Or hold stocks fairly priced, with improving fundamentals of the company. Such stocks go up.
Pay no attention to the jack*******s. It's a good play.